Table of Contents

Theranostics

• Clinical

  • EDITORIAL

    • You have access

      ProPSMA: A Callout to the Nuclear Medicine Community to Change Practices with Prospective, High-Quality Data

      Michael S. Hofman

      Journal of Nuclear Medicine May 1, 2020, 61 (5) 676-677; DOI: https://doi.org/10.2967/jnumed.120.245647

  • EDITORIAL

    • You have access

      Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging: The PSMA PET Progression Criteria

      Stefano Fanti, Boris Hadaschik and Ken Herrmann

      Journal of Nuclear Medicine May 1, 2020, 61 (5) 678-682; DOI: https://doi.org/10.2967/jnumed.119.233817

  • FEATURED ARTICLE OF THE MONTH

    • You have access

      Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair–Associated Genes

      Clemens Kratochwil, Frederik L. Giesel, Claus-Peter Heussel, Daniel Kazdal, Volker Endris, Cathleen Nientiedt, Frank Bruchertseifer, Maximilian Kippenberger, Hendrik Rathke, Jonas Leichsenring, Markus Hohenfellner, Alfred Morgenstern, Uwe Haberkorn, Stefan Duensing and Albrecht Stenzinger

      Journal of Nuclear Medicine May 1, 2020, 61 (5) 683-688; DOI: https://doi.org/10.2967/jnumed.119.234559
  • You have access

    Response Prediction of ¹⁷⁷Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase

    Hendrik Rathke, Tim Holland-Letz, Walter Mier, Paul Flechsig, Eleni Mavriopoulou, Manuel Röhrich, Klaus Kopka, Markus Hohenfellner, Frederik Lars Giesel, Uwe Haberkorn and Clemens Kratochwil

    Journal of Nuclear Medicine May 1, 2020, 61 (5) 689-695; DOI: https://doi.org/10.2967/jnumed.119.231431
  • You have access

    ¹⁸F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy

    Matthias Eiber, Markus Kroenke, Alexander Wurzer, Lena Ulbrich, Lena Jooß, Tobias Maurer, Thomas Horn, Kilian Schiller, Thomas Langbein, Gabriel Buschner, Hans-Jürgen Wester and Wolfgang Weber

    Journal of Nuclear Medicine May 1, 2020, 61 (5) 696-701; DOI: https://doi.org/10.2967/jnumed.119.234914
  • You have access

    Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, ¹⁸F-rhPSMA-7, in Patients with Prostate Cancer

    So Won Oh, Alexander Wurzer, Eugene J. Teoh, Sohee Oh, Thomas Langbein, Markus Krönke, Michael Herz, Saskia Kropf, Hans-Jürgen Wester, Wolfgang A. Weber and Matthias Eiber

    Journal of Nuclear Medicine May 1, 2020, 61 (5) 702-709; DOI: https://doi.org/10.2967/jnumed.119.234609
  • You have access

    Histologically Confirmed Diagnostic Efficacy of ¹⁸F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer

    Markus Kroenke, Alexander Wurzer, Kristina Schwamborn, Lena Ulbrich, Lena Jooß, Tobias Maurer, Thomas Horn, Isabel Rauscher, Bernhard Haller, Michael Herz, Hans-Jürgen Wester, Wolfgang A. Weber and Matthias Eiber

    Journal of Nuclear Medicine May 1, 2020, 61 (5) 710-715; DOI: https://doi.org/10.2967/jnumed.119.234906
  • You have access

    Evaluation of an Automated Module Synthesis and a Sterile Cold Kit–Based Preparation of ⁶⁸Ga-PSMA-11 in Patients with Prostate Cancer

    Letizia Calderoni, Andrea Farolfi, Davide Pianori, Elisa Maietti, Veronica Cabitza, Alessandro Lambertini, Giacomo Ricci, Silvi Telo, Filippo Lodi, Paolo Castellucci and Stefano Fanti

    Journal of Nuclear Medicine May 1, 2020, 61 (5) 716-722; DOI: https://doi.org/10.2967/jnumed.119.231605

  • BRIEF COMMUNICATION

    • You have access

      Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy

      Robert Seifert, Katharina Kessel, Martin Boegemann, Michael Köhler, Wolfgang Roll, Lars Stegger, Matthias Weckesser and Kambiz Rahbar

      Journal of Nuclear Medicine May 1, 2020, 61 (5) 723-728; DOI: https://doi.org/10.2967/jnumed.119.233429

  • BRIEF COMMUNICATION

    • You have access

      Intraindividual Comparison of ¹⁸F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer

      Felix Dietlein, Carsten Kobe, Melanie Hohberg, Boris D. Zlatopolskiy, Philipp Krapf, Heike Endepols, Philipp Täger, Jochen Hammes, Axel Heidenreich, Thorsten Persigehl, Bernd Neumaier, Alexander Drzezga and Markus Dietlein

      Journal of Nuclear Medicine May 1, 2020, 61 (5) 729-734; DOI: https://doi.org/10.2967/jnumed.119.234898

• Basic

  • Open Access

    Radiohybrid Ligands: A Novel Tracer Concept Exemplified by ¹⁸F- or ⁶⁸Ga-Labeled rhPSMA Inhibitors

    Alexander Wurzer, Daniel Di Carlo, Alexander Schmidt, Roswitha Beck, Matthias Eiber, Markus Schwaiger and Hans-Jürgen Wester

    Journal of Nuclear Medicine May 1, 2020, 61 (5) 735-742; DOI: https://doi.org/10.2967/jnumed.119.234922

  • FEATURED BASIC SCIENCE ARTICLE

    • Open Access

      Imaging DNA Damage Repair In Vivo After ¹⁷⁷Lu-DOTATATE Therapy

      Edward O’Neill, Veerle Kersemans, P. Danny Allen, Samantha Y.A. Terry, Julia Baguña Torres, Michael Mosley, Sean Smart, Boon Quan Lee, Nadia Falzone, Katherine A. Vallis, Mark W. Konijnenberg, Marion de Jong, Julie Nonnekens and Bart Cornelissen

      Journal of Nuclear Medicine May 1, 2020, 61 (5) 743-750; DOI: https://doi.org/10.2967/jnumed.119.232934